XETR
AJ91
Market cap60mUSD
Oct 07, Last price
10.60EUR
1D
-1.85%
1Q
-10.92%
Jan 2017
40.03%
IPO
145.37%
Name
DocCheck AG
Chart & performance
P/E
10.08
P/S
0.97
EPS
1.05
Div yield, %
7.08%
Shrs. gr., 5y
0.10%
Rev. gr., 5y
-2.60%
Revenues
55m
+2.84%
Net income
5m
+0.96%
CFO
6m
-19.60%
Dividend
May 29, 20261 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
DocCheck AG offers community, agency, and e-commerce services for the healthcare sector in Europe. The company develops and implements communication strategies for media on healthcare and business-to-business sectors; sells medical supplies and medical technology primarily via mail order to various medical professional groups, and invests in healthcare sectors, as well as involved in online advertising, market research, online studies, and paid content for healthcare market players. It also operates platform for information exchange, online services, and e-commerce in this market. DocCheck AG was founded in 1990 and is based in Cologne, Germany.
Key people
Joachim Pietzko
Chairman of the Supervisory Board · since 2013
Frank Nicolas Antwerpes
Chief Executive Officer, Chairman of the Management Board
Britta Boeckmann
Deputy Chairwoman of the Supervisory Board · since 2013
Helmut Rieger
Member of the Management Board, Chief Commercial Officer
Winfried Leimeister
Member of the Supervisory Board · since 1999
Headquarters & legal address
Vogelsanger Str. 66
Köln, NW 50823
DE
Köln, NW 50823
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||